{"name": "Hybrigenics",
 "permalink": "hybrigenics",
 "crunchbase_url": "http://www.crunchbase.com/company/hybrigenics",
 "homepage_url": "http://www.hybrigenics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "contact@hybrigenics.com",
 "phone_number": "+33 1 5810 3800",
 "description": "biotechnology company",
 "created_at": "Tue Sep 29 09:04:50 UTC 2009",
 "updated_at": "Tue Sep 29 09:17:38 UTC 2009",
 "overview": "\u003Cp\u003EHybrigenics S.A., a biotechnology and pharmaceutical company, focuses on therapeutics against cancer and commercializing its technology and bioinformatics platforms to identify, validate, and inhibit protein interactions. It is developing a program based on inecalcitol, a vitamin D analogue, for prostate cancer in combination with reference treatments. The company\u00e2\u20ac\u2122s research program explores the role of Ubiquitin-Specific Proteases (USPs) in the degradation of onco-proteins, and the use of proprietary USP inhibitors against various cancer types. Hybrigenics offers an access to its Yeast-Two Hybrid (Y2H) screening platform, to its bioinformatics set of tools and database, and to its chemical library and small molecule screening platform, as fee-for-service activities. The company is headquartered in Paris, France.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       17],
      "assets/images/resized/0006/1116/61116v1-max-150x150.jpg"],
     [[250,
       29],
      "assets/images/resized/0006/1116/61116v1-max-250x250.jpg"],
     [[450,
       52],
      "assets/images/resized/0006/1116/61116v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "chairman of the supervisory board",
    "person":
     {"first_name": "Daan",
      "last_name": "Ellens",
      "permalink": "daan-ellens",
      "image":
       {"available_sizes":
         [[[109,
            150],
           "assets/images/resized/0027/5891/275891v1-max-150x150.jpg"],
          [[183,
            250],
           "assets/images/resized/0027/5891/275891v1-max-250x250.jpg"],
          [[230,
            314],
           "assets/images/resized/0027/5891/275891v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$7.32M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.genomeweb.com/hybrigenics-inks-equity-facility-deal-yorkville",
    "source_description": "Hybrigenics Inks Equity Facility Deal with Yorkville",
    "raised_amount": 7320000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 9,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Yorkville Advisors",
         "permalink": "yorkville-advisors",
         "image":
          {"available_sizes":
            [[[150,
               94],
              "assets/images/resized/0006/0873/60873v1-max-150x150.png"],
             [[228,
               144],
              "assets/images/resized/0006/0873/60873v1-max-250x250.png"],
             [[228,
               144],
              "assets/images/resized/0006/0873/60873v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "3-5 impasse Reille",
    "address2": "",
    "zip_code": "75014",
    "city": "Paris",
    "state_code": null,
    "country_code": "FRA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        97],
       "assets/images/resized/0006/1117/61117v1-max-150x150.jpg"],
      [[250,
        162],
       "assets/images/resized/0006/1117/61117v1-max-250x250.jpg"],
      [[450,
        292],
       "assets/images/resized/0006/1117/61117v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}